Clinical Trials Sponsored by Christoph Nissen

Total 1210 results

Kissei Pharmaceutical Co., Ltd.

Completed

Long-term Study of KAD-1229 in Type 2 Diabetes Patients

Type 2 Diabetes

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

A Single-blind, Dose-titration Study of KWA-0711 in Patients With Chronic Constipation

Chronic Constipation

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

A Single-blind, Dose-tapering Study of KWA-0711 in Patients With Chronic Constipation

Chronic Constipation

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

A Phase III Study of PA21 in Peritoneal Dialysis Patients With Hyperphosphatemia

Peritoneal Dialysis | Hyperphosphatemia

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

A Randomized Open Label Study of KLH-2109 in Patients With Endometriosis(1)

Endometriosis

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

A Exploratory Study of KWA-0711 in Patients With Chronic Idiopathic Constipation (CIC)

Chronic Idiopathic Constipation

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

A Phase II Double Blind Comparative Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

SCD

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

A Study of KCT-0809 in Patients With Dry Eye Syndromes

Dry Eye Syndromes

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

A Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

Spinocerebellar Degeneration

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

Phase II Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

Spinocerebellar Degeneration

Japan
Christopher Bowlus, MD
Bristol-Myers Squibb

Completed

Study of Abatacept (Orencia) to Treat Primary Biliary Cirrhosis (PBC)

Primary Biliary Cirrhosis

United States
Kissei Pharmaceutical Co., Ltd.

Recruiting

An Early Phase 2 Clinical Study of KSP-0243

Colitis, Ulcerative

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain.

Endometriosis

United States, Austria, Bulgaria, Czechia, France, Poland, Romania, Spain, Ukraine, Hungary
Anne Nilsson

Completed

Effects of Plant Polar Lipids on Glucose Tolerance

Healthy

Sweden
Kissei Pharmaceutical Co., Ltd.

Completed

A Phase III Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus.

Uremic Pruritus

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

A Clinical Study of KDT-3594 in Japanese Patients With Early Parkinson's Disease

Parkinson Disease

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

A Clinical Study of KDT-3594 in Patients With Early Parkinson's Disease.

Parkinson Disease

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

Post-marketing Clinical Trial of KAD-1229 in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

An Additional Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

Spinocerebellar Degeneration

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

A Phase III Study of PA21 in Hemodialysis Patients With Hyperphosphatemia

Hemodialysis | Hyperphosphatemia

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

A Long-term Study of PA21 in Hemodialysis Patients With Hyperphosphatemia

Hemodialysis Patients With Hyperphosphatemia

Japan
Caroline Nilsson

Unknown

Treatment of Severe Peanut Allergy With Xolair (Omalizumab) and Oral Immunotherapy (FASTX)

Peanut Allergy

Sweden
Kissei Pharmaceutical Co., Ltd.

Completed

PA21 Phase II Clinical Study in Hemodialysis Patients With Hyperphosphatemia

Chronic Kidney Disease Requiring Hemodialysis

Japan
Nasser Hanna

Completed

Understanding the Molecular and Genetic Differences Between Germ Cell Tumor at the Time of the Initial Diagnosis and at Late Relapse

Neoplasms, Germ Cell and Embryonal

United States
Kissei Pharmaceutical Co., Ltd.

Completed

A Long-term Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome

Dry Eye With Sjögren's Syndrome

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

An Extension Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

Spinocerebellar Degeneration

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

A Phase II Randomized Open Label Study of KLH-2109 in Patients With Endometriosis

Endometriosis

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

A Parallel Group Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes

Dry Eye Syndromes

Japan
Ulrik Lassen

Completed

Bevacizumab and Irinotecan or Bevacizumab and Temozolomide With Concomitant Radiotherapy for Primary Glioblastoma Multiforme (GBM)

Glioblastoma Multiforme

Denmark
Kissei Pharmaceutical Co., Ltd.

Completed

A Phase II Study of KUC-7483 in Patients With Overactive Bladder

Overactive Bladder (OAB)

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

Phase 2 Study of KLS-0611 in Patients With Dry Eye Syndromes

Dry Eye Syndromes

Japan
University of Giessen
Sanofi

Completed

Comparison of Insulin Glargine and NPH Insulin at Night and at Hypoglycemia in Type 2 Diabetes (ClampHOE901)

Diabetes

Germany
Dorte Nielsen

Completed

Intra-hepatic Chemotherapy in Patients With Liver Metastases From Breast Cancer and Limited Extrahepatic Disease

Metastatic Breast Cancer | Liver Metastases

Denmark
Dorte Nielsen

Completed

Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Breast Cancer

Metastatic Breast Cancer | Liver Metastases

Denmark
Dorte Nielsen

Completed

Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Cholangiocarcinoma

Cholangiocarcinoma

Denmark
Dorte Nielsen

Terminated

HER2 PET Imaging in Breast Cancer Patients Using [68GA]ABY-025

HER2-positive Breast Cancer

Denmark
Nasser Hanna

Completed

Study of the Hypomethylating Drug Guadecitabine (SGI-110) Plus Cisplatin in Relapsed Refractory Germ Cell Tumors

Testis Cancer | Testicular Cancer | Germ Cell Tumor

United States
Kissei Pharmaceutical Co., Ltd.

Completed

Late Phase II Clinical Study of KLH-2109 in Patients With Endometriosis

Endometriosis

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

A Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

Spinocerebellar Degeneration

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

Phase II Dose-Finding Study of KWA-0711 in Patients With Chronic Constipation (CC)

Chronic Constipation

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

Phase II Study of KWA-0711 in Patients With Chronic Constipation (CC)

Chronic Constipation

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

A Phase III Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome

Dry Eye With Sjögren's Syndrome

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

A 24-week Open-label Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

Spinocerebellar Degeneration

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

Study of Absorption, Metabolism and Excretion Following a Single Oral Dose of [14C]KWA-0711 to Healthy Male Subjects

Healthy Male Subject

United Kingdom
Kissei Pharmaceutical Co., Ltd.

Completed

A Long-Term Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

Spinocerebellar Degeneration

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

Phase II Exploratory Clinical Study of KUX-1151

Hyperuricemia

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

A Late Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes

Dry Eye Syndromes

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

A Randomized, Placebo-controlled, Double-blind Study of KLH-2109 in Patients With Endometriosis (2)

Endometriosis

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

A Phase II Study of KCT-0809 in Patients With Dry Eye Syndrome

Dry Eye Syndromes

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

A Dose-finding Study of Silodosin in Patients With Urinary Calculi

Urinary Calculus

Japan

3

Subscribe